Profile
Michael Krams worked as the Vice President-Adaptive Trials at Wyeth LLC.
He then served as the Head-Quantitative Sciences at Janssen Pharmaceuticals, Inc. from 2013 to 2022.
Currently, he is the Chief Quantitative Medicine Officer at Exscientia Plc.
Dr. Krams holds a doctorate degree from Ludwig-Maximilians-Universität München.
Former positions of Michael Krams
| Companies | Position | End |
|---|---|---|
| EXSCIENTIA PLC | Chief Tech/Sci/R&D Officer | 06/06/2024 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Corporate Officer/Principal | 01/02/2022 |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Corporate Officer/Principal | - |
Training of Michael Krams
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Health Technology |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exscientia Plc
Exscientia Plc Packaged SoftwareTechnology Services Function as an investment holding company whose subsidiaries provides artificial intelligence and machine learning services | Technology Services |
- Stock Market
- Insiders
- Michael Krams
















